Flu vaccine and gout attacks

Rationing the flu vaccine.

In October 2004, the CDC announced that Chiron Corporation, chief supplier of inactivated influenza vaccine for the United States for the 2004–2005 flu season, would not be providing the 50 million vaccinations it had promised—half of the anticipated 90–100 million doses from all sources projected for the flu season. The resultant shortage set off a firestorm of concern. Well known to health ca...

Swine flu (H1N1) vaccine, 1976 and now

No one really looks forward to getting a shot, but for the vast majority of people, vaccines are very safe. Some people experience mild side effects like soreness after receiving a vaccine, and rarely people report more serious problems. In your case, the best course of action is to tell your health provider about your previous symptoms, and then follow the provider's advice for future vaccinat...

Swine flu (H1N1) vaccine, 1976 and now

No one really looks forward to getting a shot, but for the vast majority of people, vaccines are very safe. Some people experience mild side effects like soreness after receiving a vaccine, and rarely people report more serious problems. In your case, the best course of action is to tell your health provider about your previous symptoms, and then follow the provider's advice for future vaccinat...

Febuxostat for prevention of gout attacks.

(1) Febuxostat is a selective inhibitor of xanthine oxidase. Its use in the management of hyperuricemia and gout is being studied. (2) In a 52-week, phase III randomized clinical trial, febuxostat was superior to allopurinol for lowering uric acid levels. Its efficacy in preventing gout attacks was similar to that of allopurinol. Despite a similar rate of adverse effects, individuals on febuxos...

The quest for a H1N1 flu vaccine.